Moderna skyrockets 29% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients (MRNA)

5:17am PDT - May 18th, 2020    moderna - Business Insider

• Moderna announced on Monday that its early trial for its coronavirus vaccine produced antibodies in all patients. 
• Shares of the company surged 29% on Monday. 
• The company is aiming to have the vaccine ready for emergency use in the…